October 2021 saw the ISHRS (International Society for Hair Restoration Surgery) meet for a hybrid conference based in Lisbon and partially online. There were three world-renowned featured guest speakers; Dr Natasha Atanaskova Mesinkovska (University of California), Dr Mohammad Jafferany (Central Michigan University) and Dr Paul Kemp, CEO of HairClone.
Paul spoke on “The Evolution of the Promise of Hair Cloning, How Hair Cell Cloning Will Fit into Your Practice”; a short pre-interview hosted by Dr Marie Shambach can be watched here.
The ISHRS conference sees over 600 of the world’s top hair surgeons and scientists coming together to discuss advances in treatments and best practice. Based on a poll conducted by the ISHRS in 2019, cell therapy was considered the most promising solution for future hair loss treatments.
Paul gave an overview on the history of hair cloning, discussing the implications of hair follicle rejuvenation and, the more complex, regeneration (creating brand new follicles), providing insight into how far both therapies are from clinical application.
Hair follicle rejuvenation aims to rebuild existing follicles, restoring them to their original dimensions. This is the focus of HairClone’s personalised cell therapy.
